These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

89 related articles for article (PubMed ID: 17951311)

  • 61. PROPOSAL for the distribution of a certified standard for use in haemoglobinometry.
    Can Serv Med J; 1955 Mar; 11(3):115-20. PubMed ID: 14352155
    [No Abstract]   [Full Text] [Related]  

  • 62. Factors affecting pre-end-stage kidney disease haemoglobin control and outcomes following dialysis initiation: a nationwide study.
    Xu Y; Evans M; Barany P; James G; Sjölander A; Carrero JJ
    Clin Kidney J; 2021 Jul; 14(7):1780-1788. PubMed ID: 34221385
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Autosomal Dominant Polycystic Disease is Associated with Depressed Levels of Soluble Tumor Necrosis Factor-Related Apoptosis-Inducing Ligand.
    Sarı F; Yalçın AD; Genç GE; Sarıkaya M; Bisgin A; Çetinkaya R; Gümüşlü S
    Balkan Med J; 2016 Sep; 33(5):512-516. PubMed ID: 27761278
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Behavior of erythropoietin serum level in various kidney diseases].
    Heilmann E
    Verh Dtsch Ges Inn Med; 1973; 79():451-3. PubMed ID: 4597612
    [No Abstract]   [Full Text] [Related]  

  • 65. [Relation of serum erythropoietin concentration to erythropoiesis in different chronic kidney diseases and stages of kidney failure].
    Jahn CH
    Wien Klin Wochenschr; 1993; 105(11):327-9. PubMed ID: 8333200
    [No Abstract]   [Full Text] [Related]  

  • 66. [Serum erythropoietin in patients with hypernephroma, kidney cysts cystic kidneys].
    Heilmann E; Schölling R; Behrendt H; Mellin P
    Verh Dtsch Ges Inn Med; 1978; (84):207-9. PubMed ID: 742046
    [No Abstract]   [Full Text] [Related]  

  • 67. [50-year-old woman with elevated haemoglobin and iron deficiency].
    Kildahl-Andersen O; Holte J; Stalsberg H
    Tidsskr Nor Laegeforen; 2009 Sep; 129(18):1878-81. PubMed ID: 19844282
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Erythropoietin, haemoglobin, heart failure, and mortality.
    Diskin CJ
    Eur Heart J; 2008 Nov; 29(21):2695; author reply 2695-6. PubMed ID: 18786914
    [No Abstract]   [Full Text] [Related]  

  • 69. Haemoglobin and erythropoietin levels in polycystic kidney disease.
    de Almeida EA; Alho I; Marques F; Thiran C; Bicho MP; Prata M
    Nephrol Dial Transplant; 2008 Jan; 23(1):412-3. PubMed ID: 17951311
    [No Abstract]   [Full Text] [Related]  

  • 70. Blind Pew sends a black spot: the current haemoglobin controversy.
    Stevens PE
    Blood Purif; 2008; 26(1):54-8. PubMed ID: 18182797
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The CARI guidelines. Biochemical and haematological targets. Haemoglobin.
    McMahon L;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S44-56. PubMed ID: 18713123
    [No Abstract]   [Full Text] [Related]  

  • 72. Erythropoiesis-stimulating agents: favorable safety profile when used as indicated.
    Nowrousian MR; Dunst J; Vaupel P
    Strahlenther Onkol; 2008 Mar; 184(3):121-36. PubMed ID: 18330508
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Developments in the therapeutic use of erythropoiesis stimulating agents.
    Jelkmann W
    Br J Haematol; 2008 May; 141(3):287-97. PubMed ID: 18410567
    [TBL] [Abstract][Full Text] [Related]  

  • 74.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 75.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 76.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 77.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 78.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 79.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 80.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.